World
LA NYC São Paulo London Paris Lagos Dubai Delhi Singapore Tokyo Sydney
Pulse
English · Not set Change ▾

Live scores ticker: On · Turn off

Markets ticker: On · Turn off

Saved in a cookie on this device (and in your account when you are logged in). We never store your IP address.

Entities › org

IGI

9 headlines · 6 outlets · 2026-10-09 → 2026-11-18 · Wikipedia ↗ · 🔒 Follow

Latest coverage

PR Newswire: Health ·
  • Press releases
  • Country: United States

Ichnos Glenmark Innovation (IGI) gibt die Einreichung eines IND-Antrags bei der US-amerikanischen FDA für ISB 2301 bekannt, einen First-in-Class-Aktivator multispecifischer Immunzellen zur Behandlung solider Tumore

ISB 2301 zielt auf drei tumorassoziierte Antigene (TAAs) ab und aktiviert sowohl T-Zellen als auch natürliche Killerzellen (NK-Zellen) IGI plant, 2027 eine Phase-1-Studie zur Bewertung von ISB 2301 bei Patienten mit soliden Tumoren zu starten NEW YORK, 18. November 2026 /PRNewswire/ --...

PR Newswire: Health ·
  • Press releases
  • Country: United States

Ichnos Glenmark Innovation (IGI) annonce le dépôt d'une IND auprès de la FDA américaine pour l'ISB 2301, un activateur de cellules immunitaires multispecifique de première génération ciblant les tumeurs solides

L'ISB 2301 cible trois antigènes associés à la tumeur (TAA) et mobilise à la fois les lymphocytes T et les cellules NK (tueuses naturelles) IGI prévoit de lancer un essai de phase 1 évaluant l'ISB 2301 chez des patients atteints de tumeurs solides en 2027 NEW YORK, 18 novembre 2026...

PR Newswire: Technology ·
  • Press releases
  • Country: United States

Ichnos Glenmark Innovation (IGI) Announces IND Submission to U.S. FDA for ISB 2301, a First-in-Class Multispecific Immune Cell Activator Targeting Solid Tumors

ISB 2301 targets three tumor-associated antigens (TAAs) and engages both T cells and natural killer (NK) cells IGI plans to initiate a Phase 1 trial evaluating ISB 2301 in patients with solid tumors in 2027 NEW YORK, Nov. 17, 2026 /PRNewswire/ -- Ichnos Glenmark Innovation, Inc. (IGI), a...

PR Newswire: Health ·
  • Press releases
  • Country: United States

Ichnos Glenmark Innovation (IGI) Announces IND Submission to U.S. FDA for ISB 2301, a First-in-Class Multispecific Immune Cell Activator Targeting Solid Tumors

ISB 2301 targets three tumor-associated antigens (TAAs) and engages both T cells and natural killer (NK) cells IGI plans to initiate a Phase 1 trial evaluating ISB 2301 in patients with solid tumors in 2027 NEW YORK, Nov. 17, 2026 /PRNewswire/ -- Ichnos Glenmark Innovation, Inc. (IGI), a...

Explore

News

📈Trending💹Markets🏷️Topics🗞️Sources👤People & places⚖️Perspectives🌍Map🗓️Timeline

Daily

📋All daily lists

Banana Watch & guides

🍌Banana Originals🍌Banana Watch📺Live TV🌐Government live🏛️White House🗓️TV guide🔟Top 10 this week📱Shorts🏟️Official scores☀️Today's brief

Watch & listen

🎬Videos🍿Shows & Movies🎭Entertainment🎵Music🎙️Podcasts📻Live Radio & Scanners🏎️Games

Sports

🔴Sports Live📺Sports Watch📊Odds tracker

Local & weather

📍Near you🌦️Weather & radar🏳️Countries

Understand & explore

🧩Same story🔁What changed🏁Who's first🌐Web trends❓Why it's trending🔗Compare an article📜On this day⏳Time Machine🐇Rabbit hole📰Front page📚Free books🧠Daily quiz🔮Forecasts (play money)

Join

🔑Log in🍌Sign up 📲Notifications🍌Calm mode✉️Email briefing📦Offline pack

Banana News

⭐Pricing🍌Banana Coin✍️Creatorsℹ️About🛍️Shop

Banana News Single Banana

Upgrade to unlock this

See plans Log in

Free accounts get fresh bananas every day. Cancel anytime · pay by card or USDC on Base · compare all plans

↑↓ move · ↵ go · ? shortcuts

Keyboard shortcuts

Move

j / k next / previous story

o or ↵ open original

d story details

b bookmark

Go

g h home · g f front page

g t timeline · g y time machine

g b briefing · g p perspectives

g m map · g o on this day

g r rabbit hole · g w wrapped

Everywhere

/ search

Ctrl/⌘ K command palette

t cycle theme

? this help · Esc close

Shortcuts never fire while you are typing, and are off when you hold Ctrl, Alt or ⌘.

Ask Ara

Ara answers only from Banana News. Your voice stays in your browser; nothing is saved.

What each plan gets here

Every plan (Single Banana, Bunch, Crate, Banana Tree): Everything - voice, all 15 languages (Ara's own voice where it's ready, text otherwise - never a robot voice), know-how. Ara is free for everyone.

Compare plans